Motivating Patient Adherence to Allergic Rhinitis Treatments

Current Allergy and Asthma Reports

Volumn 15, Issue 3, 2015, Pages

  Bender, Bruce G ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Adherence; Allergic; Rhinitis

Indexed keywords

ALLERGIC RHINITIS; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; HOSPITALIZATION; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL INFORMATION; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREDICTOR VARIABLE; REVIEW; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; TREATMENT PLANNING; TREATMENT REFUSAL; CHRONIC DISEASE; COST BENEFIT ANALYSIS; ECONOMICS; IMMUNOLOGY; IMMUNOTHERAPY; RHINITIS, ALLERGIC;

CORTICOSTEROID;

ADRENAL CORTEX HORMONES; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; HUMANS; IMMUNOTHERAPY; PATIENT COMPLIANCE; RHINITIS, ALLERGIC;

EID: 84929012380     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-014-0507-8     Document Type: Review

References (67)

1. Sherman J, Patel P, Hutson A, Chesrown S, Hendeles L. Adherence to oral montelukast and inhaled fluticasone in children with persistent asthma. Pharmacotherapy. 2001;21:1464–7.
2. Bender B, Pedan A, Varasteh L. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol. 2006;118:899–904.
3. Vanelli M, Pedan A, Liu N, Hoar J, Messier D, Kiarsis K. The role of patient inexperience in medication discontinuation: a retrospective analysis of medication nonpersistence in seven chronic illnesses. Clin Ther. 2009;31(11):2628–52. Provides a large-scale picture of the problem of nonadherence across medical conditions.
4. Evans C, Eurich D, Remillard A, Shevchuk Y, Blackburn D. First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study. Am J Hypertens. 2012;25(2):195–203.
5. Penning-van B, Van Herksukel M, Gale R, Lammers J, Herings R. Three-year dispensing patterns with long-acting inhaled drugs, in COPD: a database analysis. Respir Med. 2011;105(2):259–65.
6. Bender B, Rankin A, Trans Z, Wamboldt F. Brief interval telephone surveys of medication adherence and asthma symptoms in the Childhood Asthma Management Program Continuation Study. Ann Allergy Asthma Immunol. 2008;101:382–6.
7. Williams L, Pladevall J, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114:1288–93. One of the few studies demonstrating a direct relationship between asthma nonadherence and healthcare outcomes.
8. Rust G, Zhang S, Reynolds J. Inhaled corticosteroid adherence and emergency department utilization among Medicaid-enrolled children with asthma. J Asthma. 2013;50:769–75.
9. Williams L, Peterson E, Wells K, et al. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. Allergy Clin Immunol. 2011;128(6):1185–91.
10. Hankin C, Cox L, Lang D, et al. Medical costs and adherence in patients receiving aqueous versus pressurized aerosol formulations of intranasal corticosteroids. Allergy Asthma Proc. 2012;33:258–64.
11. Le T, Bilderback A, Bender B, et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? Asthma. 2008;45:33–7.
12. Walders N, Kopel S, Koinis-Mitchelle D, McQuaid E. Patterns of quick-relief and long-term controller medication use in pediatric asthma. J Pediatr. 2005;146:177–82.
13. Mahadevia P, Shah S, Leibman C, Kleinman L, O’Dowd L. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis. Ann Allergy Asthma Immunol. 2001;93:345–50.
14. Hellings P, Dobbels F, Denhaeryrick K, Piersens M, Ceuppes J, De Geest S. Explorative study on patient’s perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis. Clin Transit Allergy. 2012;2(1):9.
15. Sher E, Ross J. Intranasal corticosteroids: the role of patient preference and satisfaction. Allergy Asthma Proc. 2014;35(1):24–33.
16. Marogna M, Spadolini I, Massolo A, Canonica G, Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol. 2010;126(5):969–75. Demonstrates the declining benefits of sublingual immunotherapy accompanying decreasing treatment intervals.
17. Hankin C, Cox L, Lang D, et al. Allergy immunotherapy among medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol. 2008;121:227–32.
18. Senna G, Lombardi C, Canonica G, Passalacqua G. How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers’ viewpoint. J Allergy Clin Immunol. 2010;126:668–9.
19. Kiel M, Roder E, Gerth van Wijk P, Al M, Hop W, Rutten-van Molken MPMH. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132:353–60. Provides a direct comparison between SLIT and SCIT adherence.
20. Shaw R, Bosworth H. Baseline medication adherence and blood pressure in a 24-month longitudinal hypertension study. J Clin Nurs. 2012;21:1401–6.
21. Wiegant P, McCombs J, Wang J. Factors of hyperlipidemia medication adherence in a nationwide health plan. Am J Manage Care. 2012;18:1930199.
22. Huetsch J, Uman J, Udris E, Au D. Predictors of adherence to inhaled medications among veterans with COPD. J Gen Intern Med. 2012;27(11):1506–12.
23. Nam S, Chesla C, Stotts N, Kroon L, Janson S. Barriers to diabetes management: patient and provider factors. Diabetes Res Clin Pract. 2011;93(1):1–9.
24. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.
25. Schiff G, Fung S, Speruff T, McNutt R. Decompensated heart failure: symptoms, patterns of onset, and contributing factors. Am J Med. 2003;114:625–30.
26. Senst B, Achusim L, Genest R. Practical approach to determine costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58:1126–32.
27. Bosworth H, Grnater B, Mendys P. Medication adherence: a call for action. Am Heart. 2011;162:412–24.
28. Desal M, Oppenheimer J. Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep. 2011;11(6):454–64.
29. Drotar D, Bonner M. Influences on adherence to pediatric asthma treatment: a review of correlates and predictors. J Dev Behav Pediatr. 2009;30(6):574–82.
30. Hernandez D, Schmaling K. Understanding and resolving adherence problems. Clin Rev Allergy Immunol. 2004;27(2):65–73.
31. Bukstein D, Luskin A, Farrar J. The reality of adherence to rhinitis treatment: identifying and overcoming the barriers. Allergy Asthma Proc. 2011;32:265–71.
32. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006;130:65S–72.
33. Bender B, Bender S. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin N Am. 2005;25:107–30.
34. Bender B, Long A, Parasuraman B, Tran Z. Factors influencing patient decisions about the use of asthma controller medication. Ann Asthma. 2007;98:322–8.
35. Miller T, Dimattao M. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Metab Syndr Obes. 2013;6(6):421–6.
36. Derose S, Green K, Marrett E, et al. Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med. 2013;173(1):38–43.
37. Wilson S, Strub P, Buist A, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Am J Respir Crit Care Med. 2010;181(6):566–77. One of the best studies of the benefits of shared decision making to treatment adherence.
38. Renders C. Interventions to improve the management of diabetes mellitus in primary care, outpatient, and community settings. Cochrane Database of Syst Rev No 1. 2002;CD001481.
39. Dickinson W, Dickinson L, Nutting P, et al. Practice facilitation to improve diabetes care in primary care: a report from the EPIC randomized clinical trial. Ann Fam Med. 2014;12(1):8–16.
40. van Boven J, Tommelein E, Boussery K, et al. Improving inhaler adherence in patients with chronic obstructive pulmonary disease: a cost-effectiveness analysis. Respir Med. 2014:15–66.
41. Lozano P, Finkelstein J, Carey V, et al. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med. 2004;158(9):875–83.
42. Bobbins L, Pfeiffer K, Maler K, LaDrig S, Malcolm B. Treatment fidelity of motivational interviewing delivered by a school nurse to increase girls’ physical activity. J Sch Nurs. 2012;February 28(1):70–78.
43. Tollison S, Mastroleo N, Mallett K, Witkiewitz K, Ray A, Larimer M. The relationship between baseline drinking status, peer motivational interviewing microskills and drinking outcomes in a brief alcohol intervention for matriculating college students. A replication. Behav Ther. 2013;44(1):137–51.
44. D’Amico E, Hunter S, Miles J, Ewing B, Osilla K. A randomized controlled trial of a group motivational interviewing intervention for adolescents with a first time alcohol or drug offense. J Subst Abuse Treat. 2013;45(5).
45. Cook P, Bremer R, Ayala A, Kahook MY. Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherence. Clin Ophthalmol. 2010;4:1091–101.
46. Barkhof E, Meijer C, de Sonneville L, Linszen D, de Haan L. The effect of motivational interviewing on medication adherence and hospitalization rates in nonadherent patients with multi-episode schizophrenia. Schizophr Bull. 2013;39(6):1242–51.
47. Bender B. Can healthcare organizations improve health behavior and treatment adherence? Popul Health Manag. 2014;17:71–8.
48. Bender B. Nonadherence to COPD treatment: what have we learned and what do we do next? COPD. 2012;9:209–10.
49. Bender B. Communication strategies to improve adherence with asthma medications. Vol Pediatric Allergy: Principles and Practice. New York, NY: Elsevier; 2010
50. Essential elements of communication in medical encounters: the Kalamazoo Consensus Statement. Paper presented at: Bayer-Fetzer Conference on Physician-Patient Communication in Medical Education 20012001.
51. DiMatteo M. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ Couns. 2004;55:339–44.
52. Boulware L, Daumit G, Frick K, Minkovitz C, Lawrnece R, Powe N. An evidence-based review of patient-centered behavioral interventions for hypertension. Am J Prev Med. 2001;1(21):221–32.
53. Borrelli B, Riekert K, Weinstien A. Brief motivational interviewing as a clinical strategy to promote asthma medication adherence. J Allergy Clin Immunol. 2007;120(5):1023–30.
54. Wamboldt F, Bender B. Adolescent decision-making about use of inhaled asthma controller medication: results from focus groups with participants from a prior longitudinal study. J Asthma. 2011;48:741–50.
55. Dalcin Pde T, Grutcki D, Laporte P, et al. Impact of a short-term educational intervention on adherence to asthma treatment and on asthma control. J Bras Pneumol. 2011;37:19–27.
56. Irwin R, Richardson N. Patient-focused care: using the right tools. 2006;130:73–82. A clear and concise exploration of the importance of patient-centered care.
57. Linnemann D, Blaiss M. Selection of patient for sublingual versus subcutaneous immunotherapy. Immunotherapy. 2014;6(7):871–84.
58. Sher E, Ross J. Intranasal corticosteroids: the role of patient preference and satisfaction. Allergy Asthma Proc. 2014;35(Number 1):24–33.
59. Noble P, Fuller-Lafreniere S, Meftah M, Dwyer M. Challenges in outcome measurement: discrepancies between patient and provider definitions of success. Clin Orthop Relat Res. 2013;471(11):3437–45.
60. Wilson S, Strub P, Buist A, et al. Shared treatment decision making improves adherence and outcomes in poorly controlled asthma. Better Outcomes of Asthma Treatment (BOAT) Study Group. Am J Respir Crit Care Med. 2010;181(6):566–77.
61. Bosworth H, Olsen M, Neasry A, et al. Take control of your blood pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns. 2008;70:338–47.
62. Ziller V, Kyvenmitakis I, Knoll D, Storch A, Hars O, Hadji P. Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment—the COMPAS study. BMC Cancer. BMC Cancer. 2013;(13):407.
63. Montes J, Gomez-Beneyto M, Maurino J. A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia. Psychiatry Res. 2012;(2–3):89–95.
64. Stacy J, Schwartz S, Ershoff D, Shreve M. Incorporating tailored interactive patient solutions using interactive voice response technology to improve statin adherence: results of a randomized clinical trial in a managed care setting. Popul Health Manag. 2009;12(5):241–54.
65. Vollmer W, Krishner M, Peter S, et al. Use and impact of an automated telephone outreach system for asthma in a managed care setting. Am J Manage Care. 2006;12:725–33.
66. Bender B, Cvietusa P, Goodrich G, et al. A pragmatic controlled trial of healthcare technologies to improve adherence to pediatric asthma treatment. JAMA Pediatr. In press. Demonstrates utilization of health information and communication technology to improve adherence.
67. Wang K, Wang C, Xi L, et al. A randomized controlled trial to assess adherence to allergic rhinitis treatment following a daily short message services (SMS) via the mobile phone. Int Arch Allergy Immunol. 2013;163(1):51–8.